Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Breast Neoplasms 369Carcinoma, Non-Small-Cell Lung 315Neoplasms 289Prostatic Neoplasms 245Colorectal Neoplasms 214Multiple Myeloma 182Lung Neoplasms 170Neoplasm Metastasis 152Leukemia, Myeloid, Acute 137Pancreatic Neoplasms 130Squamous Cell Carcinoma of Head and Neck 127Ovarian Neoplasms 117Melanoma 98Carcinoma, Renal Cell 94Recurrence 87Stomach Neoplasms 81Precursor Cell Lymphoblastic Leukemia-Lymphoma 80Carcinoma, Hepatocellular 80Lymphoma, Non-Hodgkin 79Head and Neck Neoplasms 79Lymphoma 78Glioblastoma 78Triple Negative Breast Neoplasms 76Lymphoma, Large B-Cell, Diffuse 75Urinary Bladder Neoplasms 69Endometrial Neoplasms 68Brain Neoplasms 68Leukemia, Lymphocytic, Chronic, B-Cell 65Uterine Cervical Neoplasms 62Lymphoma, Follicular 62

Interventions

Radiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Prostatic Hyperplasia × 30 days × Clear all
NCT04879940 2026-05-20

Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Active not recruiting
17 enrolled
Genitourinary

Prostatic Hyperplasia, Prostatic Neoplasms

NCT06511141 2026-05-12

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

Axonics, Inc.

Phase NA Recruiting
150 enrolled
Genitourinary

Prostatic Hyperplasia, Prostatic Neoplasms, Urinary Bladder, Overactive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡